Search alternatives:
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
e decrease » we decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
e decrease » we decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1
-
2
All-Atom Simulations Reveal the Effect of Membrane Composition on the Signaling of the NKG2A/CD94/HLA‑E Immune Receptor Complex
Published 2024“…In this study, we employed all-atom molecular dynamics simulations to investigate the impact of different membrane compositions on the conformational dynamics of the NKG2A/CD94/HLA-E immune receptor complex, a key negative regulator of natural killer cell cytotoxic activity. …”
-
3
Data Sheet 1_Use of HLA desensitization in the management of renal transplant recipients in Europe.pdf
Published 2025“…As the degree of sensitization increases, the likelihood of finding a compatible organ decreases. Desensitization is the process of reducing recipient anti-HLA antibodies to acceptable levels to allow transplantation. …”
-
4
Data Sheet 1_Case Report: HLA-DRB1 04:01 found in a child with adenovirus type 2 -linked hepatitis.pdf
Published 2025“…Adeno-associated virus type 2 (AAV2) was identified as a cause, with most affected children having the HLA-DRB1 04:01 genotype. …”
-
5
Data Sheet 2_Case Report: HLA-DRB1 04:01 found in a child with adenovirus type 2 -linked hepatitis.pdf
Published 2025“…Adeno-associated virus type 2 (AAV2) was identified as a cause, with most affected children having the HLA-DRB1 04:01 genotype. …”
-
6
Data Sheet 1_HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies.pdf
Published 2024“…Thirty patients experienced graft loss at a median of 39 months after dnDSA detection: 9/18 (50%) HLA-I only, 17/33 (52%) HLA-II only, and 4/4 (100%) both classes. …”
-
7
Data Sheet 2_HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies.pdf
Published 2024“…Thirty patients experienced graft loss at a median of 39 months after dnDSA detection: 9/18 (50%) HLA-I only, 17/33 (52%) HLA-II only, and 4/4 (100%) both classes. …”
-
8
ZIKV infection enriches the HLA Class I pathway in brain tumour cells.
Published 2025“…<p><b>(A)</b> Heatmap plotting Log2(LFQ intensity) values of the top and bottom 50 ranked proteins in the ZIKV-infected USP7-ATRT cell global proteome. …”
-
9
Image 6_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
10
Image 9_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
11
Data Sheet 1_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.docx
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
12
Image 5_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
13
Data Sheet 2_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.xlsx
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
14
Image 3_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
15
Data Sheet 3_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.xlsx
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
16
Image 7_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
17
Image 1_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
18
Image 2_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
19
Image 4_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”
-
20
Image 8_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg
Published 2025“…Both conditions share a strong association with the genetic risk factor, human leukocyte antigen (HLA)-B27. …”